OptiPharm CEO Hyun Il Kim Raises Stake to 2.16% From 2.12%

PUBT · 2d ago
OptiPharm CEO Hyun Il Kim Raises Stake to 2.16% From 2.12%
  • OptiPharm CEO Hyun Il Kim increased his stake to 2.16% from 2.12%.
  • Open-market purchases totaling 5,876 common shares between Oct. 30 and Nov. 9, 2026, increased his holdings to 317,526 shares.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. OptiPharm Co. Ltd. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261106000265), on November 06, 2026, and is solely responsible for the information contained therein.